Evidence map›Paper›PMID 22045586›Full record

ArticleCurrent protocols in microbiology2011

Vibriocidal assays to determine the antibody titer of patient sera samples.

Mike S Son, Ronald K Taylor

Open access · greenAbstract read
In one paragraph

Article in Current protocols in microbiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Mike S SonDartmouth Medical School, Hanover, New Hampshire, USA.
Ronald K Taylor
Dartmouth College · US

Funding

Genetic Determinants of Virulence in Vibrio choleraeR37AI025096 · NIAID · DARTMOUTH COLLEGE · PI TAYLOR, RONALD K · 2007 to 2015
$4.3M
HIERARCHY WITHIN ENVIRONMENTAL REGULONSR01AI039654 · NIAID · DARTMOUTH COLLEGE · PI TAYLOR, RONALD K · 1996 to 2011
$3.3M
GENTICS DETERMINATION OF VIRULENCE OF VIBRIO CHOLERAER01AI025096 · NIAID · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI SKORUPSKI, KAREN A · 1989 to 2016
$3.1M
Hierarchy Within Environmental RegulonsR56AI039654 · NIAID · DARTMOUTH COLLEGE · PI TAYLOR, RONALD K · 2014 to 2014
$405k
GENETIC DETERMINANTS OF VIRULENCE IN VIBRIO CHOLERAER22AI025096 · NIAID · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI TAYLOR, RONALD K · 1987 to 1991
–
NIAID NIH HHS AI025096NIAID NIH HHS AI039654NIAID NIH HHS R01 AI025096NIAID NIH HHS R01 AI039654NIAID NIH HHS R37 AI025096NIAID NIH HHS R56 AI039654
6 · The paper itself

Abstract

The vibriocidal titer assay can be used to detect antibodies against Vibrio cholerae in serum samples, serving as an indicator of prior infection and potential protection against cholera. The assay can be utilized in research and clinical settings to test the effectiveness of vaccines, and also in epidemiological studies relevant to cholera transmission and surveillance. This unit outlines the steps involved in conducting an easily interpreted colorimetric vibriocidal titer assay with a relatively short turnaround time for results of around 8 hr, with final result observations in 24 hr. The assay can also be easily scaled up or down to accommodate as many or as few serum samples available and is not V. cholerae strain specific.

Indexed as

Antibodies, BacterialCholeraColorimetryHumansSerum Bactericidal Antibody AssayVibrio choleraeAntibodies, Bacterial

Identifiers

PMID22045586
PMCPMC3228410
OpenAlexW1907758307

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.